STEPHANIE FARMER: Open Payments
NPI 1518982305 · BRYANT, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,119 in 76 payments from 17 companies in 2025. Trend: 2023 $1,022 · 2024 $1,026 · 2025 $1,119
Food & beverage: $1,119
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $279 |
| Novo Nordisk Inc | 11 | $183 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $122 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $91 |
| Lilly USA, LLC | 5 | $79 |
| Dexcom, Inc. | 3 | $55 |
| GlaxoSmithKline, LLC. | 3 | $49 |
| Amgen Inc. | 3 | $44 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| PFIZER INC. | 2 | $31 |
Products named: UBRELVY, JARDIANCE, CAPLYTA, Rybelsus, QULIPTA, VRAYLAR, Ozempic, Dexcom G6 Transmitter.
Industry payments across AR — which companies pay providers there.
